| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.58 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.55 | 0.01 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.41 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.39 | 0.07 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.39 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.38 | 0.05 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.27 | 0.2 |